The management of treatment-resistant schizophrenia

Research output: Contribution to journalShort survey

6 Scopus citations


Several important developments in the pharmacotherapy of treatment-resistant schizophrenia have occurred over the past year. These developments include the resolution of questions related to the clinical application and safety of clozapine, the widespread introduction of risperidone, and new approaches to the treatment of negative symptoms and cognitive impairment. These developments will be critically examined and future challenges for the management of treatment-resistant schizophrenia will be discussed.

Original languageEnglish (US)
Pages (from-to)41-44
Number of pages4
JournalCurrent Opinion in Psychiatry
Issue number1
StatePublished - Jan 1 1995
Externally publishedYes

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'The management of treatment-resistant schizophrenia'. Together they form a unique fingerprint.

  • Cite this